skip to primary navigationskip to content
 

Semarion

semarion

Semarion has been founded by Tarun Vemulkar (c2012) and Jeroen Verheyen (a2014). Tarun and Jeroen won the NanoDTC Translational Prize to jointly develop the technology that led to the formation of Semarion.

Semarion’s mission is to triple the success rate of clinical trials by providing novel in-depth protein fingerprint insight into a patient’s state of health.

Drug development suffers from high failure rates during clinical trial phases 2 (70%) and 3 (50%) which can be overcome by patient stratification and precision medicine. Mass spectroscopy (protein fingerprints) and low-biomarker assays (1-3 proteins) have been used to identify high response patient populations. These technologies are, however, not scalable or give minimal insight. Further, genomic tools cannot provide the same level of insight into a patient’s state of health and disease.

Semarion’s proteomics platform uses novel magnetic nanoparticles with highly tuneable magnetic, optical, and surface properties. This allows the Semarion platform to simultaneously quantify 1,000s of proteins in small samples, in an accurate, affordable, and automated way.

Semarion will provide tools and services to pharma companies and clinical research organisations. Our technology can enable high-level patient stratification while generating additional data on efficacy, toxicity, off-target effects, and new drug targets.

RSS Feed Latest news

Black researchers shaping the future

Oct 13, 2018

As the UK marks Black History Month, researchers from across the University talk about their route to Cambridge, their inspiration and their motivation.

‘Symposium as Sea’ in Antarctica

Oct 05, 2018

c2014 student Hannah Laeverenz Schlogelhofer has returned from an expedition to Antarctica as part of the Homeward Bound Leadership Programme.

NanoDTC Associates Programme

Sep 26, 2018

We are now accepting applications from current PhD students in Cambridge to become affiliated to the NanoDTC. Deadline 25th Oct.

Diversity Champ Carmen wins IoP Medal and Prize

Jul 11, 2018

Congratulations Carmen Palacios Berraquero (c2013) for winning the 2018 Jocelyn Bell Burnell Medal and Prize – an IoP award for outstanding early career female physicists